Seon Woong Kim
Overview
Explore the profile of Seon Woong Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Choi J, Byun H, Yoon T, Carter C, Do H
Opt Express
. 2023 Oct;
31(20):32504-32515.
PMID: 37859052
Molecular oxygen (O) concentration is measured by employing nanosecond laser-induced plasmas (ns-LIP) over a broad temperature spectrum ranging from 300 K to 1000 K, in the presence of an additional...
2.
Park A, Kim S, Kim S, Kwon K
Probiotics Antimicrob Proteins
. 2021 May;
13(6):1780-1789.
PMID: 34018140
Current antibiotics have limited action mode, which makes it difficult for the antibiotics dealing with the emergence of bacteria resisting the existing antibiotics. As a need for new bacteriolytic agents...
3.
Shrestha J, Hwang G, Lee T, Kim S, Oh Y, Kwon Y, et al.
Molecules
. 2019 Dec;
24(23).
PMID: 31810327
Sphingosine-1-phosphate (S1P) regulates the proliferation of various cells and promotes the growth of cancer cells. Sphingosine kinase (SK), which transforms sphingosine into S1P, has two isotypes: SK1 and SK2. To...
4.
Kim S, Lee T, Oh Y, Shin S, Lee J, Kim S, et al.
Chem Pharm Bull (Tokyo)
. 2019 Jun;
67(6):599-603.
PMID: 31155566
The PF-543 is known as a potent and selective inhibitor of sphingosine kinase (SK) 1 amongst all the SK inhibitors known to date. In a recently reported study by Pfizer...
5.
Kim D, Kim S, Song J, Kim S, Kwon K
BMC Biotechnol
. 2019 Feb;
19(1):13.
PMID: 30770741
Background: Despite the growing demand for antimicrobial peptides (AMPs) for clinical use as an alternative approach against antibiotic-resistant bacteria, the manufacture of AMPs relies on expensive, small-scale chemical methods. The...
6.
Shrestha J, Ki S, Shin S, Kim S, Lee J, Jun H, et al.
Molecules
. 2018 Oct;
23(11).
PMID: 30355990
FTY720 inhibits various cancers through PP2A activation. The structure of FTY720 is also used as a basic structure for the design of sphingosine kinase (SK) inhibitors. We have synthesized derivatives...
7.
Lee T, Moon H, Kim S, Shrestha J, Shin S, Lee J, et al.
Chem Pharm Bull (Tokyo)
. 2018 Oct;
66(10):1015-1018.
PMID: 30270236
FTY720 is employed for the treatment of multiple sclerosis and exerts apoptotic effects on various cancers through protein phosphatase 2A (PP2A) activation. In compound 4, the dihydroxy head group of...